down arrow

Tianjin Lisheng Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000NJ9
CNY
20.33
0.59 (2.99%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Tianjin Lisheng Pharmaceutical Co., Ltd.
Why is Tianjin Lisheng Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.82%
  • The company has been able to generate a Return on Capital Employed (avg) of 1.82% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -0.70% and Operating profit at -19.02% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
  • NET PROFIT(9M) At CNY 135.07 MM has Grown at -59.09%
  • OPERATING CASH FLOW(Y) Lowest at CNY 40.29 MM
  • INTEREST(HY) At CNY 1.32 MM has Grown at 12.45%
4
With ROE of 8.56%, it has a attractive valuation with a 1.16 Price to Book Value
  • Over the past year, while the stock has generated a return of 23.90%, its profits have risen by 15.4% ; the PEG ratio of the company is 0.9
  • At the current price, the company has a high dividend yield of 1.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Tianjin Lisheng Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tianjin Lisheng Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Tianjin Lisheng Pharmaceutical Co., Ltd.
-100.0%
0.85
37.71%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-0.70%
EBIT Growth (5y)
-19.02%
EBIT to Interest (avg)
34.34
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.25
Tax Ratio
14.16%
Dividend Payout Ratio
48.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.82%
ROE (avg)
3.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.16
EV to EBIT
95.14
EV to EBITDA
30.99
EV to Capital Employed
1.27
EV to Sales
2.88
PEG Ratio
0.90
Dividend Yield
1.11%
ROCE (Latest)
1.34%
ROE (Latest)
8.56%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -14.6% (YoY

CASH AND EQV(HY)

Highest at CNY 4,488.46 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 2.66%

-10What is not working for the Company
NET PROFIT(9M)

At CNY 135.07 MM has Grown at -59.09%

OPERATING CASH FLOW(Y)

Lowest at CNY 40.29 MM

INTEREST(HY)

At CNY 1.32 MM has Grown at 12.45%

Here's what is working for Tianjin Lisheng Pharmaceutical Co., Ltd.
Cash and Eqv
Highest at CNY 4,488.46 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 2.66%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -14.6% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin Lisheng Pharmaceutical Co., Ltd.
Net Profit
At CNY 135.07 MM has Grown at -59.09%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest
At CNY 1.32 MM has Grown at 12.45%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 40.29 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."